Clinical and genetic analysis of Costa Rican patients with Parkinson’s disease
Authors:
- Gabriel Torrealba-AcostaGTGabriel Torrealba-Acosta
- Eric YuEYEric Yu
- Tanya Lobo-PradaTLTanya Lobo-Prada
- Javier Ruiz-MartínezJRJavier Ruiz-Martínez
- Ana Gorostidi-PagolaAGAna Gorostidi-Pagola
- Ziv Gan-OrZGZiv Gan-Or
- Kenneth Carazo-CéspedesKCKenneth Carazo-Céspedes
- Jaime Fornaguera-TríasJFJaime Fornaguera-Trías
Preprint
Abstract
Background: Parkinson’s disease (PD) involves environmental risk and protective factors as well as genetic variance. Most of the research in genomics has been done in subjects of European ancestry leading to sampling bias and leaving Latin American populations underrepresented. Objective: We sought to phenotype and genotype Costa Rican PD cases and controls. Methods: We enrolled 118 PD patients with 97 unrelated controls. Collected information included demographics, exposure to risk and protective factors, motor and cognitive assessments. We sequenced coding and untranslated regions in familial PD and atypical parkinsonism-associated genes including GBA, SNCA, VPS35, LRRK2, GCH1, PRKN, PINK1, DJ-1, VPS13C, ATP13A2 . Results: Mean age of PD probands was 62.12 ± 13.51 years, 57.6% were male. Prevalence of risk and protective factors reached 30%. Physical activity significantly correlated with better motor performance despite years of disease. Increased years of education were significantly associated with better cognitive function, whereas hallucinations, falls, mood disorders and coffee consumption correlated with worse cognitive performance. We did not identify an association between tested genes and PD or any damaging homozygous or compound heterozygous variants. Rare variants in LRRK2 were nominally associated with PD, six were located between amino acids p.1620-1623 in the C-terminal-of-ROC (COR) domain of LRRK2. Nonsynonymous GBA variants (p.T369M, p.N370S, p.L444P) were identified in three healthy individuals. One PD patient carried a pathogenic GCH1 variant, p.K224R. Conclusion: This is the first study that reports on sociodemographic, risk factors, clinical presentation and genetics of Costa Rican patients with PD.Keywords
All Related Versions
- Published version: Frontiers in Neurology, 12.
This publication has 49 references indexed in Scilit:
- Update of the MDS research criteria for prodromal Parkinson's diseaseMovement Disorders, 2019
- GBA-Associated Parkinson’s Disease and Other SynucleinopathiesCurrent Neurology and Neuroscience Reports, 2018
- Parkinson diseaseNature Reviews Disease Primers, 2017
- Genomics is failing on diversityNature, 2016
- Genetics of Parkinson's disease – state of the art, 2013Parkinsonism & Related Disorders, 2014
- The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristicsNeuroscience Letters, 2013
- Meta‐analysis of early nonmotor features and risk factors for Parkinson diseaseAnnals of Neurology, 2012
- Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's diseaseNeuroscience Letters, 2010
- A study of LRRK2 mutations and Parkinson's disease in BrazilNeuroscience Letters, 2008
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997